JP Morgan Chase’s Generation Bio GBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-689
| Closed | -$3.91K | – | 7667 |
|
|
2025
Q4 | $3.91K | Buy |
689
+2
| +0.3% | +$11 | ﹤0.01% | 6844 |
|
|
2025
Q3 | $4.2K | Buy |
687
+254
| +59% | +$1.32K | ﹤0.01% | 6802 |
|
|
2025
Q2 | $1.39K | Sell |
433
-19,763
| -98% | -$76.1K | ﹤0.01% | 6583 |
|
|
2025
Q1 | $81.8K | Sell |
20,196
-9,575
| -32% | -$67.3K | ﹤0.01% | 5662 |
|
|
2024
Q4 | $316K | Buy |
29,771
+12,752
| +75% | +$227K | ﹤0.01% | 5277 |
|
|
2024
Q3 | $420K | Sell |
17,019
-350
| -2% | -$9.26K | ﹤0.01% | 5013 |
|
|
2024
Q2 | $490K | Sell |
17,369
-9,439
| -35% | -$307K | ﹤0.01% | 4701 |
|
|
2024
Q1 | $1.09M | Sell |
26,808
-1,781
| -6% | -$41.9K | ﹤0.01% | 4286 |
|
|
2023
Q4 | $472K | Sell |
28,589
-112,456
| -80% | -$1.96M | ﹤0.01% | 4838 |
|
|
2023
Q3 | $5.35M | Buy |
141,045
+50,913
| +56% | +$2.41M | ﹤0.01% | 2789 |
|
|
2023
Q2 | $4.96M | Buy |
90,132
+43,747
| +94% | +$2.01M | ﹤0.01% | 2870 |
|
|
2023
Q1 | $1.99M | Buy |
46,385
+271
| +0.6% | +$13.1K | ﹤0.01% | 3543 |
|
|
2022
Q4 | $1.81M | Buy |
46,114
+306
| +0.7% | +$16.1K | ﹤0.01% | 3636 |
|
|
2022
Q3 | $2.43M | Sell |
45,808
-18,618
| -29% | -$1.16M | ﹤0.01% | 3315 |
|
|
2022
Q2 | $4.23M | Sell |
64,426
-1,602
| -2% | -$105K | ﹤0.01% | 2932 |
|
|
2022
Q1 | $4.85M | Buy |
66,028
+9,827
| +17% | +$569K | ﹤0.01% | 3037 |
|
|
2021
Q4 | $3.98M | Sell |
56,201
-124,797
| -69% | -$21.8M | ﹤0.01% | 3257 |
|
|
2021
Q3 | $45.4M | Buy |
180,998
+34,389
| +23% | +$8.23M | 0.01% | 1228 |
|
|
2021
Q2 | $39.4M | Sell |
146,609
-4,668
| -3% | -$1.4M | ﹤0.01% | 1342 |
|
|
2021
Q1 | $43.1M | Buy |
151,277
+73,370
| +94% | +$23.5M | 0.01% | 1230 |
|
|
2020
Q4 | $22.1M | Buy |
77,907
+25,244
| +48% | +$8.1M | ﹤0.01% | 1544 |
|
|
2020
Q3 | $16.3M | Buy |
52,663
+5,968
| +13% | +$1.43M | ﹤0.01% | 1642 |
|
|
2020
Q2 | $9.81M | Buy |
+46,695
| New | +$10.4M | ﹤0.01% | 1910 |
|
Other funds holding GBIO
JP Morgan Chase's GBIO Position: Q1 2026 in Review
JP Morgan Chase sold out of Generation Bio (GBIO) in Q1 2026, closing a stake of 689 shares — an estimated $3.91K sold.
JP Morgan Chase first reported a position in GBIO in Q2 2020 and held it in 23 quarters. The position peaked at $45.4M in Q3 2021. 2 funds tracked by Wall St. Rank hold GBIO as of Q1 2026.
- JP Morgan Chase reported no remaining Generation Bio position as of Q1 2026 after selling out during the quarter.
- JP Morgan Chase sold 689 Generation Bio shares in Q1 2026, an estimated $3.91K.
- JP Morgan Chase first reported a position in Generation Bio in Q2 2020 and held it in 23 quarters.
- JP Morgan Chase's Generation Bio position peaked at $45.4M in Q3 2021.
- 2 funds tracked by Wall St. Rank held Generation Bio as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.